V
5.50
0.32 (6.18%)
AIStockmoo Score
-0.3
| Analyst Consensus | 0.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | -0.25 |
| 52 Weeks Range | ||
| Median | 15.00 (172.73%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Maxim Group | 02 Oct 2025 | 15.00 (172.73%) | Buy | 5.36 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 08 Dec 2025 | Announcement | Vyome Reports Positive Final Phase 2 Results for VT-1953; Plans to Advance Into Pivotal Study For FDA Approval |
| 25 Nov 2025 | Announcement | Vyome Appoints Renowned Medical Oncologist, Dr. Aditya Bardia, as Senior Medical Advisor to Guide the Development of MFW Program |
| 18 Nov 2025 | Announcement | Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing |
| 04 Nov 2025 | Announcement | Vyome Holdings Announces Results of Annual Shareholder Meeting |
| 29 Sep 2025 | Announcement | Vyome Holdings Acquires MIT AI Spinout Oculo Health |
| 09 Sep 2025 | Announcement | Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |